These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

808 related articles for article (PubMed ID: 21070886)

  • 1. Differential outcome of cardiac resynchronization therapy in ischemic cardiomyopathy and idiopathic dilated cardiomyopathy.
    McLeod CJ; Shen WK; Rea RF; Friedman PA; Hayes DL; Wokhlu A; Webster TL; Wiste HJ; Hodge DO; Bradley DJ; Hammill SC; Packer DL; Cha YM
    Heart Rhythm; 2011 Mar; 8(3):377-82. PubMed ID: 21070886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adding the implantable cardioverter-defibrillator to cardiac resynchronization therapy is associated with improved long-term survival in ischaemic, but not in non-ischaemic cardiomyopathy.
    Witt CT; Kronborg MB; Nohr EA; Mortensen PT; Gerdes C; Jensen HK; Nielsen JC
    Europace; 2016 Mar; 18(3):413-9. PubMed ID: 26378089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response to preventive cardiac resynchronization therapy in patients with ischaemic and nonischaemic cardiomyopathy in MADIT-CRT.
    Barsheshet A; Goldenberg I; Moss AJ; Eldar M; Huang DT; McNitt S; Klein HU; Hall WJ; Brown MW; Goldberger JJ; Goldstein RE; Schuger C; Zareba W; Daubert JP
    Eur Heart J; 2011 Jul; 32(13):1622-30. PubMed ID: 21075774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Right ventricular myocardial function in patients with either idiopathic or ischemic dilated cardiomyopathy without clinical sign of right heart failure: effects of cardiac resynchronization therapy.
    D'Andrea A; Salerno G; Scarafile R; Riegler L; Gravino R; Castaldo F; Cocchia R; Limongelli G; Romano M; Calabrò P; Nigro G; Cuomo S; Bossone E; Caso P; Calabrò R
    Pacing Clin Electrophysiol; 2009 Aug; 32(8):1017-29. PubMed ID: 19659622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adding Defibrillation Therapy to Cardiac Resynchronization on the Basis of the Myocardial Substrate.
    Barra S; Boveda S; Providência R; Sadoul N; Duehmke R; Reitan C; Borgquist R; Narayanan K; Hidden-Lucet F; Klug D; Defaye P; Gras D; Anselme F; Leclercq C; Hermida JS; Deharo JC; Looi KL; Chow AW; Virdee M; Fynn S; Le Heuzey JY; Marijon E; Agarwal S;
    J Am Coll Cardiol; 2017 Apr; 69(13):1669-1678. PubMed ID: 28359511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of ventricular tachyarrhythmia characteristics in patients with idiopathic dilated or ischemic cardiomyopathy and defibrillators implanted for primary prevention.
    Streitner F; Kuschyk J; Dietrich C; Mahl E; Streitner I; Doesch C; Veltmann C; Schimpf R; Wolpert C; Borggrefe M
    Clin Cardiol; 2011 Oct; 34(10):604-9. PubMed ID: 21887690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time-dependent benefit of preventive cardiac resynchronization therapy after myocardial infarction.
    Barsheshet A; Moss AJ; Eldar M; Huang DT; Hall WJ; Klein HU; McNitt S; Steinberg JS; Wilber DJ; Zareba W; Goldenberg I
    Eur Heart J; 2011 Jul; 32(13):1614-21. PubMed ID: 21075773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of myocardial viability and left ventricular lead location on clinical outcome in cardiac resynchronization therapy recipients with ischemic cardiomyopathy.
    Bose A; Kandala J; Upadhyay GA; Riedl L; Ahmado I; Padmanabhan R; Gewirtz H; Mulligan LJ; Singh JP
    J Cardiovasc Electrophysiol; 2014 May; 25(5):507-513. PubMed ID: 24350650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of cardiac resynchronization therapy on reverse remodeling and relation to outcome: multicenter automatic defibrillator implantation trial: cardiac resynchronization therapy.
    Solomon SD; Foster E; Bourgoun M; Shah A; Viloria E; Brown MW; Hall WJ; Pfeffer MA; Moss AJ;
    Circulation; 2010 Sep; 122(10):985-92. PubMed ID: 20733097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-Term Echocardiographic Outcome in Super-Responders to Cardiac Resynchronization Therapy and the Association With Mortality and Defibrillator Therapy.
    van der Heijden AC; Höke U; Thijssen J; Willem Borleffs CJ; Wolterbeek R; Schalij MJ; van Erven L
    Am J Cardiol; 2016 Oct; 118(8):1217-1224. PubMed ID: 27586169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcomes after prophylactic ICD and CRT-D implantation in nonischemic patients: Analysis from a nationwide database of daily remote-monitoring transmissions.
    Forleo GB; Solimene F; Pisanò EC; Zanotto G; Calvi V; Pignalberi C; Maglia G; Iacopino S; Quartieri F; Biffi M; Caravati F; Curnis A; Capucci A; Senatore G; Santamaria M; Della Bella P; Manzo M; Giacopelli D; Gargaro A; D'Onofrio A
    J Cardiovasc Electrophysiol; 2019 Sep; 30(9):1626-1635. PubMed ID: 31165517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary prevention of sudden cardiac death in a nonischemic dilated cardiomyopathy population: reappraisal of the role of programmed ventricular stimulation.
    Gatzoulis KA; Vouliotis AI; Tsiachris D; Salourou M; Archontakis S; Dilaveris P; Gialernios T; Arsenos P; Karystinos G; Sideris S; Kallikazaros I; Stefanadis C
    Circ Arrhythm Electrophysiol; 2013 Jun; 6(3):504-12. PubMed ID: 23588627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A cohort study of cardiac resynchronization therapy in patients with chronic Chagas cardiomyopathy.
    Martinelli Filho M; de Lima Peixoto G; de Siqueira SF; Martins SAM; Nishioka SAD; Pedrosa AAA; Teixeira RA; Dos Santos JX; Costa R; Kalil Filho R; Ramires JAF
    Europace; 2018 Nov; 20(11):1813-1818. PubMed ID: 29509903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving survival rates of patients with idiopathic dilated cardiomyopathy in Tuscany over 3 decades: impact of evidence-based management.
    Castelli G; Fornaro A; Ciaccheri M; Dolara A; Troiani V; Tomberli B; Olivotto I; Gensini GF
    Circ Heart Fail; 2013 Sep; 6(5):913-21. PubMed ID: 23888044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Left ventricular ejection fraction normalization in cardiac resynchronization therapy and risk of ventricular arrhythmias and clinical outcomes: results from the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) trial.
    Ruwald MH; Solomon SD; Foster E; Kutyifa V; Ruwald AC; Sherazi S; McNitt S; Jons C; Moss AJ; Zareba W
    Circulation; 2014 Dec; 130(25):2278-86. PubMed ID: 25301831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of shocks on mortality in patients with ischemic or dilated cardiomyopathy and defibrillators implanted for primary prevention.
    Streitner F; Herrmann T; Kuschyk J; Lang S; Doesch C; Papavassiliu T; Streitner I; Veltmann C; Haghi D; Borggrefe M
    PLoS One; 2013; 8(5):e63911. PubMed ID: 23675514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of cardiac resynchronization therapy with implantable cardioverter defibrillator versus cardiac resynchronization therapy with pacemaker on mortality in heart failure patients: results of a high-volume, single-centre experience.
    Kutyifa V; Geller L; Bogyi P; Zima E; Aktas MK; Ozcan EE; Becker D; Nagy VK; Kosztin A; Szilagyi S; Merkely B
    Eur J Heart Fail; 2014 Dec; 16(12):1323-30. PubMed ID: 25379962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex Differences in Long-Term Outcomes With Cardiac Resynchronization Therapy in Mild Heart Failure Patients With Left Bundle Branch Block.
    Biton Y; Zareba W; Goldenberg I; Klein H; McNitt S; Polonsky B; Moss AJ; Kutyifa V;
    J Am Heart Assoc; 2015 Jun; 4(7):. PubMed ID: 26124205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ambulatory blood pressure monitoring, 2D-echo and clinical variables relating to cardiac events in ischaemic cardiomyopathy following cardioverter-defibrillator implantation.
    Antonini L; Pasceri V; Mollica C; Ficili S; Poti G; Aquilani S; Santini M; La Rocca S
    J Cardiovasc Med (Hagerstown); 2011 May; 12(5):334-9. PubMed ID: 21487343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Profound differences in prognostic impact of left ventricular reverse remodeling after cardiac resynchronization therapy relate to heart failure etiology.
    Martens P; Nijst P; Verbrugge FH; Dupont M; Tang WHW; Mullens W
    Heart Rhythm; 2018 Jan; 15(1):130-136. PubMed ID: 28843420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.